View clinical trials related to Pregnancy.
Filter by:This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
It has been seen that primiparous pregnant women experience similar problems during the transition to motherhood, and these problems affect both their self-evaluation, physical problems in the postpartum period, and maternal attachment. It is thought that the correct and adequate care and training received from health professionals will be effective in the solution of all these interconnected situations. The study aims to determine the effect of the "Transition to Motherhood Program (TMOP)" applied to primiparous pregnant women on self-assessment, postpartum problems, and maternal attachment. MethoThis research method is a randomized, control group pretest-posttest experimental research. The population of the study consisted of pregnant women who were registered to two Family Health Centers between December 2019 and December 2021 and met the inclusion criteria, the sample consisted who agreed to participate in the study (experimental group: 38, control group: 38).In the study, Personal Information Form, Prenatal Self-Assessment Scale, Prenatal Attachment Scale were applied to all pregnant women in the sample group as pre-test applications. Based on Meleis' Transition Theory, the Transition to Motherhood Program was applied to the pregnant women in the experimental group. The post-test application of the research was carried out in the sixth weeks and fourth postpartum months. At the sixth week of the postpartum period, the Postpartum Self-Assessment Scale, Postpartum Physical Symptom Scale, Maternal Attachment Scale; at the fourth month of the postpartum period, the Maternal Attachment Scale was used. In data analysis, dependent sample t test, ki square, mann whitney u tests will use. Necessary permissions were obtained for the study.
This study investigates the effect of education and counseling on anxiety and depression in nullipar women.
Study to determine if a user-friendly medical abortion regimen using letrozole and misoprostol is safe and acceptable.
This study aims to test the following hypotheses in a longitudinal, observational study in pregnant women who will be randomized to received either a Blinded or Unblinded CGM sensor and followed-up 6-12 weeks after delivery: 1. CF-CGM device is well tolerable and accurate for glucose level monitoring in women with a normal pregnancy. 2. CF-CGM device is well tolerable and acceptable in women with GDM who are required intensive glucose monitoring on a daily basis during pregnancy and even after delivery. 3. There are trimester-specific glucose profiles observed in the whole pregnancy. 4. Pregnancies complicated with GDM would show a specific glucose profile that is different from non-GDM pregnancies (e.g. greater daily fluctuations, more episodes and longer duration of glucose spikes after meal). 5. There is a good correlation between one-day glucose profile and OGTT test at 24-31 weeks gestation GDM screening. 6. Pre-GDM screening glucose profiles is predictive of GDM diagnosis at 24-31 weeks gestation.
Open-label, two-arm, randomized multicenter study to investigate the safety, tolerability, and pharmacokinetics (PK), and potential interactions between dolutegravir (DTG) and rifapentine (RPT) during pregnancy in people with HIV when RPT is given with isoniazid (INH) daily for 4 weeks (1HP) or weekly for 3 months (3HP) as part of tuberculosis (TB) preventive therapy (TPT). Adults (age ≥18) who are pregnant with a singleton pregnancy (confirmed by ultrasound) at a gestational age of 20-34 weeks and virally suppressed on an existing DTG-based plus two nucleoside reverse transcriptase inhibitors (NRTI) antiretroviral (ART) regimen for at least four weeks may participate.
Bempedoic acid pregnancy surveillance program
This is a randomized, sham-controlled trial to determine whether treatment with transcranial direct current stimulation (tDCS) is superior to a sham condition at reducing the symptoms of depression in pregnant people with moderate to severe depression. The study aims to enrol 156 participants across all sites. Data collection occurs at baseline, immediately after treatment, every 4 weeks during pregnancy and 4-, 12-, 26- and 52-weeks postpartum
The purpose of this study is to assess the effectiveness of mobile phone based appointment reminder notifications sent through Health Recording App (HERA) in increasing the uptake of 4 World Health Organization recommended prenatal visits among Syrian refugee population.
The purpose of this online follow-up study is to investigate health app use in pregnant women and through a pilot intervention trial investigate whether the addition of evidence-based information on health-promoting lifestyle delivered via the health app has an effect on lifestyle habits (gestational weight, diet quality and physical activity) during pregnancy.